HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell functionA Blueprint for HIV Vaccine DiscoveryAntigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cellsThe major genetic determinants of HIV-1 control affect HLA class I peptide presentation.Challenges in the treatment of HIV and HCV coinfection.Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection.HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection.Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.Induction of Gag-specific CD4 T cell responses during acute HIV infection is associated with improved viral control.Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infectionHow a single patient influenced HIV research--15-year follow-up.Emergence of individual HIV-specific CD8 T cell responses during primary HIV-1 infection can determine long-term disease outcomeEmerging concepts on T follicular helper cell dynamics in HIV infectionEpithelial adhesion molecules can inhibit HIV-1-specific CD8⁺ T-cell functionsLack of protection following passive transfer of polyclonal highly functional low-dose non-neutralizing antibodiesInduction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals.HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome.Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence.Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia.Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I allelesAntigen-Specific Antibody Glycosylation Is Regulated via Vaccination.CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytesPreserved function of regulatory T cells in chronic HIV-1 infection despite decreased numbers in blood and tissue.Expansion of HIV-specific T follicular helper cells in chronic HIV infection.Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.Review of tipranavir in the treatment of drug-resistant HIV.Expansion of Inefficient HIV-Specific CD8 T Cells during Acute Infection.Harnessing CD4⁺ T cell responses in HIV vaccine development.Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activityImmune-driven recombination and loss of control after HIV superinfection.Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infectionRapid loss of dendritic cell and monocyte responses to TLR ligands following venipunctureProtective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1.Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells.Antiviral CD8+ T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion.TGF-β receptor maintains CD4 T helper cell identity during chronic viral infectionsThe role of IFN-gamma Elispot assay in HIV vaccine research.
P50
Q24600313-0C0BBB21-164B-485E-8606-74255FDF6716Q26829865-A1E0B754-9DA6-4506-A688-9F24E885BA81Q28754733-6F8CF57C-08EF-4517-B662-422D8FF6E142Q29417018-4F68EDA6-41CD-49A9-8F14-909B0530010AQ30389282-45AB9B0A-8687-4866-97E3-939DA69AB93DQ30469621-5D0CD7CB-5171-490B-9D5F-EC8A1F145D33Q33262230-F31849A0-0E8A-40E0-9B58-1682CE839153Q33427803-543077D9-0EC3-4EA3-A7D4-87000A30B945Q33649753-179CD32E-1900-41B1-8A00-EBD5B5E17598Q33744069-A199FFEE-DA28-4A33-AFC9-ADBB6F049DF9Q33851717-37E2DADA-CBBD-431C-A9CA-6B838156B005Q34295972-F350903B-DA4F-4DC3-B581-ED386472C0D5Q34403835-5E6FEA28-7AF1-49FD-80AD-738233FA8D4AQ34593765-49B25888-9EA5-49FA-98BB-1DE51FE37E2EQ34687653-1A75ECE4-B039-491F-A2B5-61EBEC8AB58AQ35029429-478B67EA-4701-46E9-9603-B81487678BC0Q35167400-9915618E-9BFE-4EE6-B081-4D45F4EEDA3EQ35621704-F60CFF76-993E-4802-96F6-311F7620A2CDQ35665966-207148ED-EBD7-49E0-80E8-DB62D5BB5513Q35679577-E4C06967-BAAD-4064-99B8-54D19266B761Q35861240-F963BE9A-0DF4-4285-9A5A-0B7C2CCC9BC0Q35914562-B15A9A0C-C552-400A-B76A-9CDD6EF94560Q35959717-3A9D1D13-B51C-4562-B424-946E33673E58Q36086676-F7CE6221-89D8-4FE6-820E-5054417470FDQ36153756-9F321D3F-BEE2-4822-A085-1F17D03B4E23Q36190755-44638839-BAE8-4451-B241-C89B76C7EE09Q36229197-3C0DEE11-0CB6-4283-BEC0-B9EB5E3165E6Q36642990-527318FF-FE8D-4348-804A-31525266FE39Q36736388-F246E92E-DC37-42A4-992A-8C990396A0E2Q36766715-9E0C029C-94C4-4075-AE21-74E9470B2ABDQ36797342-5D4244F9-6F57-4CFE-9411-AE5698CA85F5Q36851900-E538E611-4EB0-4983-A30D-6AE229645C3DQ36898637-DADE6901-81E9-42A1-91FF-F6BBADBAA5A2Q37036594-2C96913D-FBCC-4748-B0BD-A76256688807Q37099792-A2D6291A-E26D-4404-B9C3-A3BDABCE0ADEQ37245752-FE4BDBEB-E2A3-4D5B-A6D8-C7CCB918C659Q37256675-0B80E34F-BCAB-4F08-863F-A3776FCBD0CDQ37362291-004A1157-C22E-4131-A45E-EAB54FCB1B2CQ37395668-49D693A5-B9F9-4860-8F72-A868A2A9D88AQ37413964-5D045DD3-67DE-4C9A-8A88-B1B24F177D42
P50
Q89831161-0a9ae72f-4edf-a550-0692-c14c04d73e6dQ90158442-d96d50d1-43ef-6162-b173-37808f0e4b0bQ90284430-87990a87-4131-3abf-191b-a1167c9a141bQ91611469-31f5158c-43a7-3d42-7a63-fad7dbc199edQ91611663-600f88c0-4121-8a1b-fdd2-48ea39126635Q96052476-ff28ad14-4a11-286b-64d8-94d9e2a59cd6Q96240524-454093ba-4616-d940-9bb8-de5d9231a441
P5030
description
Duits onderzoeker
@nl
German virologist
@en
German virologist
@en-ca
German virologist
@en-gb
deutscher HIV-Forscher, Professor für Virologie
@de
virólogo alemán
@es
عالم فيروسات ألماني
@ar
ドイツのHIV研究者、疫学者
@ja
name
Hendrik Streeck
@ast
Hendrik Streeck
@de
Hendrik Streeck
@en
Hendrik Streeck
@es
Hendrik Streeck
@nl
Hendrik Streeck
@sl
Гендрік Штрек
@uk
Штрек, Хендрик
@ru
ヘンドリック・ストリーク
@ja
type
label
Hendrik Streeck
@ast
Hendrik Streeck
@de
Hendrik Streeck
@en
Hendrik Streeck
@es
Hendrik Streeck
@nl
Hendrik Streeck
@sl
Гендрік Штрек
@uk
Штрек, Хендрик
@ru
ヘンドリック・ストリーク
@ja
altLabel
H Streeck
@en
H. Streeck
@en
Streeck H
@en
Streeck H.
@en
Streeck
@en
prefLabel
Hendrik Streeck
@ast
Hendrik Streeck
@de
Hendrik Streeck
@en
Hendrik Streeck
@es
Hendrik Streeck
@nl
Hendrik Streeck
@sl
Гендрік Штрек
@uk
Штрек, Хендрик
@ru
ヘンドリック・ストリーク
@ja
P101
P106
P214
P227
P1153
9233144900
P19
P2003
hendrikstreeck
P2013
hendrikstreeck
P2038
Hendrik_Streeck